{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:44:06Z","timestamp":1771332246617,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Ther Perspect"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s40267-017-0380-3","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T14:18:02Z","timestamp":1486563482000},"page":"188-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-1421","authenticated-orcid":false,"given":"Cristiano","family":"Matos","sequence":"first","affiliation":[]},{"given":"L.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"J.","family":"Joaquim","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"380_CR1","first-page":"1","volume-title":"The importance of pharmacovigilance: safety monitoring of medicinal products","author":"World Health Organization. WHO","year":"2002","unstructured":"World Health Organization. WHO. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva: World Health Organization; 2002. p. 1\u201348."},{"issue":"8","key":"380_CR2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-008-0475-9","volume":"64","author":"L H\u00e4rmark","year":"2008","unstructured":"H\u00e4rmark L, Van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743\u201352.","journal-title":"Eur J Clin Pharmacol"},{"key":"380_CR3","unstructured":"EC. Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance. Directive 2001\/83\/EC on the Community code relating to medicinal products for human us [online]. Available from URL: http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.douri=OJ:L:2010:348:0074:0099:EN:PDF . Accessed 30 May 2011; 2010."},{"issue":"7","key":"380_CR4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-015-1867-2","volume":"71","author":"C Matos","year":"2015","unstructured":"Matos C, van Hunsel F, Joaquim J. Are consumers ready to take part in the pharmacovigilance system? A Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;71(7):883\u201390.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"380_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ijpp.12078","volume":"22","author":"J Marques","year":"2014","unstructured":"Marques J, Ribeiro-Vaz I, Pereira AC, et al. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Int J Pharm Pract. 2014;22(4):275\u201382.","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"380_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2753.2001.00295.x","volume":"7","author":"A Figueiras","year":"2001","unstructured":"Figueiras A, Tato F, Fontai\u00f1as J, et al. Physicians\u2019 attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract. 2001;7(4):347\u201354.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"380_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2011.03944.x","volume":"72","author":"P Gavaza","year":"2011","unstructured":"Gavaza P, Brown CM, Lawson KA, et al. Influence of attitudes on pharmacists\u2019 intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol. 2011;72(1):143\u201352.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"380_CR8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40264-013-0028-8","volume":"36","author":"R Leone","year":"2013","unstructured":"Leone R, Moretti U, D\u2019Incau P, et al. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Drug Saf. 2013;36(4):267\u201376.","journal-title":"Drug Saf"},{"issue":"3","key":"380_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pds.702","volume":"11","author":"AC Grootheest Van","year":"2002","unstructured":"Van Grootheest AC, Van Puijenbroek EP, de Jong-van den Berg LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"380_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11586620-000000000-00000","volume":"34","author":"J-J Borg","year":"2011","unstructured":"Borg J-J, Aislaitner G, Pirozynski M, et al. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? Drug Saf. 2011;34(3):187\u201397.","journal-title":"Drug Saf"},{"issue":"5","key":"380_CR11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11096-014-0004-0","volume":"36","author":"S Steurbaut","year":"2014","unstructured":"Steurbaut S, Hanssens Y. Pharmacovigilance: empowering healthcare professionals and patients. Int J Clin Pharm. 2014;36(5):859\u201362.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"380_CR12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1742-7843.2006.pto_286.x","volume":"98","author":"PC Waller","year":"2006","unstructured":"Waller PC. Making the most of spontaneous adverse drug reaction reporting. Basic Clin Pharmacol Toxicol. 2006;98(3):320\u20133.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"380_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2125.2006.02746.x","volume":"63","author":"A Blenkinsopp","year":"2007","unstructured":"Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148\u201356.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"380_CR14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2125.2011.03990.x","volume":"72","author":"C Anderson","year":"2011","unstructured":"Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806\u201322.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"380_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"MT Herdeiro","year":"2006","unstructured":"Herdeiro MT, Figueiras A, Pol\u00f3nia J, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting. Drug Saf. 2006;29(4):331\u201340.","journal-title":"Drug Saf"},{"issue":"Supp 1","key":"380_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14740338.2014.939582","volume":"13","author":"E Parretta","year":"2014","unstructured":"Parretta E, Rafaniello C, Magro L, et al. Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy. Expert Opin Drug Saf. 2014;13(Supp 1):21\u20139.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"380_CR17","first-page":"63","volume":"7","author":"ML Pellegrino","year":"2015","unstructured":"Pellegrino ML, Desiderio V, Mores N, et al. The role of the pharmacist in patient reporting of adverse drug reactions: the Italian interregional project [in Italian]. G Ital di Farm e Farm. 2015;7(1):63\u201374.","journal-title":"G Ital di Farm e Farm"},{"issue":"2","key":"380_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s40267-016-0355-9","volume":"33","author":"C Matos","year":"2017","unstructured":"Matos C, Joaquim J, Pires T. Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal. Drugs Ther Perspect. 2017;33(2):86\u201392.","journal-title":"Drugs Ther Perspect"},{"key":"380_CR19","unstructured":"Infarmed. Estat\u00edstica do Medicamento e Produtos de Sa\u00fade 2014; 2014."},{"key":"380_CR20","volume-title":"Statistical power analysis for the behavior science","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrance Eribaum Association; 1988.","edition":"2nd"},{"issue":"4","key":"380_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.20344\/amp.67","volume":"25","author":"MT Herdeiro","year":"2012","unstructured":"Herdeiro MT, Ferreira M, Ribeiro-Vaz I, et al. The Portuguese pharmacovigilance system. Acta M\u00e9dica Port. 2012;25(4):241\u20139.","journal-title":"Acta M\u00e9dica Port"},{"issue":"5","key":"380_CR22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2125.1996.tb00040.x","volume":"41","author":"WH Inman","year":"1996","unstructured":"Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5):434.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"380_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions. Drug Saf. 2009;32(1):19\u201331.","journal-title":"Drug Saf"},{"issue":"3","key":"380_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jonm.12337","volume":"24","author":"JI Marques","year":"2016","unstructured":"Marques JI,\u00a0Pol\u00f3nia J,\u00a0Figueiras AG, et al.\u00a0Nurses\u2019 attitudes and spontaneous adverse drug reaction reporting: a case\u2013control study in Portugal.\u00a0J Nurs Manag. 2016;24(3):409\u201316.","journal-title":"J Nurs Manag"},{"issue":"9","key":"380_CR25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s40267-015-0227-8","volume":"31","author":"M Duarte","year":"2015","unstructured":"Duarte M, Ferreira P, Soares M, et al. Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Perspect. 2015;31(9):316\u201322.","journal-title":"Drugs Ther Perspect"},{"key":"380_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4172\/2329-6887.1000193","volume":"4","author":"HZ Toklu","year":"2016","unstructured":"Toklu HZ, Soyalan M, G\u00fcltekin O, et al. The knowledge and attitude of the healthcare professionals towards pharmacovigilance and adverse drug reaction reporting in northern Cyprus. J Pharmacovigil. 2016;4:193. doi: 10.4172\/2329-6887.1000193 .","journal-title":"J Pharmacovigil"},{"issue":"6","key":"380_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002280050314","volume":"52","author":"KJ Belton","year":"1997","unstructured":"Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol. 1997;52(6):423\u20137.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"380_CR28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/pds.3306","volume":"22","author":"J Krska","year":"2013","unstructured":"Krska J. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs). Pharmacoepidemiol Drug Saf. 2013;22(10):1130\u20133.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"380_CR29","unstructured":"INFARMED. Sistema Nacional de Farmacovigil\u00e2ncia (SNF): Notifica\u00e7\u00f5es e Casos de RAM - Ano\/2015; 2016."}],"container-title":["Drugs & Therapy Perspectives"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-017-0380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40267-017-0380-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-017-0380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T10:53:25Z","timestamp":1719053605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40267-017-0380-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1007\/s40267-017-0380-3","relation":{},"ISSN":["1172-0360","1179-1977"],"issn-type":[{"value":"1172-0360","type":"print"},{"value":"1179-1977","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}